CK Life Sciences Int'l., (Holdings) Inc. (0775.HK)
HKD 0.79
(11.27%)
HKD 0.79
(11.27%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 486.79 Million HKD | -44.04% |
| 2022 | 469.5 Million HKD | -2.13% |
| 2021 | 449.14 Million HKD | 24.5% |
| 2020 | 353.61 Million HKD | -19.37% |
| 2019 | 475.21 Million HKD | -16.32% |
| 2018 | 521.02 Million HKD | 22.04% |
| 2017 | 327.45 Million HKD | -7.07% |
| 2016 | 452.06 Million HKD | 12.65% |
| 2015 | 433.71 Million HKD | -1.27% |
| 2014 | 446.73 Million HKD | 4.03% |
| 2013 | 457.48 Million HKD | 6.98% |
| 2012 | 493.53 Million HKD | 40.32% |
| 2011 | 352.27 Million HKD | 4.77% |
| 2010 | 336.25 Million HKD | -1.4% |
| 2009 | 341.33 Million HKD | 330.88% |
| 2008 | -166.08 Million HKD | -203.41% |
| 2007 | 147.96 Million HKD | -33.43% |
| 2006 | 204.56 Million HKD | -30.3% |
| 2005 | 72.28 Million HKD | 1127.1% |
| 2004 | 25.08 Million HKD | 11.77% |
| 2003 | 22.44 Million HKD | 153.07% |
| 2002 | -42.29 Million HKD | 17.44% |
| 2001 | -51.22 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 234.24 Million HKD | 0.0% |
| 2023 Q2 | 172.2 Million HKD | 0.0% |
| 2023 Q4 | 147.76 Million HKD | 0.0% |
| 2023 FY | - HKD | -44.04% |
| 2022 Q4 | 158.08 Million HKD | 0.0% |
| 2022 Q2 | 183.41 Million HKD | 0.0% |
| 2022 FY | - HKD | -2.13% |
| 2021 Q2 | 227.44 Million HKD | 0.0% |
| 2021 FY | - HKD | 24.5% |
| 2021 Q4 | 123.46 Million HKD | 0.0% |
| 2020 Q2 | 253.89 Million HKD | 0.0% |
| 2020 FY | - HKD | -19.37% |
| 2020 Q4 | -61.89 Million HKD | 0.0% |
| 2019 FY | - HKD | -16.32% |
| 2019 Q4 | 62.09 Million HKD | 0.0% |
| 2019 Q2 | 317.26 Million HKD | 0.0% |
| 2018 Q4 | 236.36 Million HKD | 0.0% |
| 2018 FY | - HKD | 22.04% |
| 2018 Q2 | 284.65 Million HKD | 0.0% |
| 2017 FY | - HKD | -7.07% |
| 2017 Q2 | 286.2 Million HKD | 0.0% |
| 2017 Q4 | 41.24 Million HKD | 0.0% |
| 2016 FY | - HKD | 12.65% |
| 2016 Q4 | 167.2 Million HKD | 0.0% |
| 2016 Q2 | 284.85 Million HKD | 0.0% |
| 2015 FY | - HKD | -1.27% |
| 2015 Q2 | 218.8 Million HKD | 0.0% |
| 2015 Q4 | 214.91 Million HKD | 0.0% |
| 2014 FY | - HKD | 4.03% |
| 2014 Q2 | 214.68 Million HKD | 0.0% |
| 2014 Q4 | 232.04 Million HKD | 0.0% |
| 2013 Q2 | 228.7 Million HKD | 0.0% |
| 2013 FY | - HKD | 6.98% |
| 2013 Q4 | 228.77 Million HKD | 0.0% |
| 2012 FY | - HKD | 40.32% |
| 2012 Q4 | - HKD | 0.0% |
| 2012 Q2 | - HKD | 0.0% |
| 2011 Q2 | - HKD | 0.0% |
| 2011 FY | - HKD | 4.77% |
| 2011 Q4 | - HKD | 0.0% |
| 2010 Q4 | - HKD | 0.0% |
| 2010 FY | - HKD | -1.4% |
| 2010 Q2 | - HKD | 0.0% |
| 2009 FY | - HKD | 330.88% |
| 2009 Q4 | - HKD | 0.0% |
| 2008 FY | - HKD | -203.41% |
| 2007 FY | - HKD | -33.43% |
| 2006 FY | - HKD | -30.3% |
| 2005 FY | - HKD | 1127.1% |
| 2004 FY | - HKD | 11.77% |
| 2003 FY | - HKD | 153.07% |
| 2002 FY | - HKD | 17.44% |
| 2001 FY | - HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 91.23 Million HKD | -433.569% |